Your shopping cart is currently empty

Avibactam sodium hydrate (NXL-104 hydrate) is a highly effective β-lactamase inhibitor that inhibits β-lactamases TEM-1 and CTX-M-15, as well as the carbapenemase produced by Klebsiella pneumoniae and carbapenem-resistant Enterobacteriaceae.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $30 | - | In Stock | |
| 5 mg | $61 | - | In Stock |
| Description | Avibactam sodium hydrate (NXL-104 hydrate) is a highly effective β-lactamase inhibitor that inhibits β-lactamases TEM-1 and CTX-M-15, as well as the carbapenemase produced by Klebsiella pneumoniae and carbapenem-resistant Enterobacteriaceae. |
| Targets&IC50 | TEM1:8 nM, CTX-M-15:5 nM |
| In vitro | Avibactam sodium hydrate is a covalent and reversible non-β-lactam β-lactamase inhibitor with IC50 values of 8 nM and 5 nM for the β-lactamases TEM-1 and CTX-M-15, respectively.[1] Although Avibactam sodium hydrate has little or no antimicrobial activity, it effectively inhibits class A and C β-lactamases, and has no significant effect on the activities of metallo-β-lactamases and Fusobacterium oxysporum OXA carbapenemase. [2] When Avibactam sodium hydrate was used in combination with ceftazidime (concentration range 0-256 mg/L), it inhibited the growth of 16 blaKPC-2-positive and 1 blaOXA-232-positive strains of K. pneumoniae with MIC50 and MIC90 of 8 mg/L.[4] |
| In vivo | In a mouse model infected with K. pneumoniae Y8 strain, Avibactam sodium hydrate in combination with ceftazidime (0.375 mg/g; subcutaneous injection; every 8 hours for 10 days) significantly inhibited bacterial growth and demonstrated some therapeutic effect. [3] After a single subcutaneous injection of Avibactam sodium hydrate (64 mg/kg), its estimated mean terminal half-life against Pseudomonas aeruginosa infection in a neutropenic mouse lung infection model was 0.24 hours. [3] |
| Synonyms | NXL-104 hydrate |
| Molecular Weight | 305.24 |
| Formula | C7H12N3NaO7S |
| Cas No. | 2938989-90-1 |
| Smiles | NC([C@H]1[N@@]2C(N([C@@](CC1)([H])C2)OS(=O)([O-])=O)=O)=O.[Na+].O |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 150 mg/mL (491.42 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.